Temporary vascular access for hemodialysis treatment - Current guidelines and future directions

Contributions to Nephrology

Volumn 142, Issue , 2004, Pages 94-111

  Weijmer, Marcel C ^a,b   Ter Wee, Piet M ^b  

^a ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL VENOUS CATHETERIZATION; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; EQUIPMENT; EQUIPMENT DESIGN; FEMALE; FORECASTING; HUMAN; INDWELLING CATHETER; MALE; NETHERLANDS; PRACTICE GUIDELINE; RENAL REPLACEMENT THERAPY; REVIEW; SENSITIVITY AND SPECIFICITY; STANDARD; TIME;

CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; EQUIPMENT DESIGN; EQUIPMENT SAFETY; FEMALE; FORECASTING; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; NETHERLANDS; PRACTICE GUIDELINES; RENAL DIALYSIS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 1342311420     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (60)

1. Pisoni RL, Young EW, Dykstra DM, Greenwood RN, Hecking E, Gillespie B, Wolfe RA, Goodkin DA, Held PJ: Vascular access use in Europe and the United States: Results from the DOPPS. Kidney Int 2002;61:305-316.
2. Little MA, O'Riordan A, Lucey B, Farrell M, Lee M, Conlon PJ, Walshe JJ: A prospective study of complications associated with cuffed, tunnelled haemodialysis catheters. Nephrol Dial Transplant 2001;16:2194-2200.
3. Weijmer MC, ter Wee PM: Temporary vascular access for hemodialysis treatment. Current guidelines and future directions. Contrib Nephrol. Basel, Karger, 2002, vol 137, pp 38-45.
4. Kairaitis LK, Gottlieb T: Outcome and complications of temporary haemodialysis catheters. Nephrol Dial Transplant 1999;14:1710-1714.
5. Tokars JI, Light P, Anderson J, Miller ER, Parrish J, Armistead N, Jarvis WR, Gehr T: A prospective study of vascular access infections at seven outpatient hemodialysis centers. Am J Kidney Dis 2001;37:1232-1240.
6. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: Update 2000. Am J Kidney Dis 2001;37:S137-S181.
7. Oliver MJ, Callery SM, Thorpe KE, Schwab SJ, Churchill DN: Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: A prospective study. Kidney Int 2000;58:2543-2545.
8. Weijmer MC, Vervloet MG, ter Wee PM: Tunneled cuffed and temporary jugular catheters for hemodialysis access: Comparison of outcome. J Am Soc Nephrol 2000;11:A1066.
9. Cimochowski GE, Worley E, Rutherford WE, Sartain J, Blondin J, Harter H: Superiority of the internal jugular over the subclavian access for temporary dialysis. Nephron 1990;54:154-161.
10. Schillinger F, Schillinger D, Montagnac R, Milcent T: Postcatheterisation vein stenosis in haemodialysis: Comparative angiographic study of 50 subclavian and 50 internal jugular accesses. Nephrol Dial Transplant 1991;6:722-724.
11. Merrer J, De Jonghe B, Golliot F, Lefrant JY, Raffy B, Barre E, Rigaud JP, Casciani D, Misset B, Bosquet C, Outin H, Brun-Buisson C, Nitenberg G: Complications of femoral and subclavian venous catheterization in critically ill patients: A randomized controlled trial. JAMA 2001;286: 700-707.
12. Po CL, Koolpe HA, Allen S, Alvez LD, Raja RM: Transhepatic PermCath for hemodialysis. Am J Kidney Dis 1994;24:590-591.
13. Gupta A, Karak PK, Saddekni S: Translumbar inferior vena cava catheter for long-term hemodialysis. J Am Soc Nephrol 1995;5:2094-2097.
14. Punzi M, Ferro F, Petrosino F, Masiello P, Villari V, Sica V, Cavaliere G: Use of an intra-aortic Tesio catheter as vascular access for haemodialysis. Nephrol Dial Transplant 2003;18:830-832.
15. Al-Wakeel JS, Milwalli AH, Malik GH, Huraib S, Al-Mohaya S, Abu-Aisha H, Memon N: Dual-lumen femoral vein catheterization as vascular access for hemodialysis - A prospective study. Angiology 1998;49:557-562.
16. Kumwenda MJ: Two different techniques and outcomes for insertion of long-term tunnelled haemodialysis catheters. Nephrol Dial Transplant 1997;12:1013-1016.
17. Wivell W, Bettmann MA, Baxter B, Langdon DR, Remilliard B, Chobanian M: Outcomes and performance of the Tesio twin catheter system placed for hemodialysis access. Radiology 2001; 221:697-703.
18. Oliver MJ, Edwards LJ, Treleaven DJ, Lambert K, Margetts PJ: Randomized study of temporary hemodialysis catheters. Int J Artif Organs 2002;25:40-44.
19. Warady BA, Sullivan EK, Alexander SR: Lessons from the peritoneal dialysis patient database: A report of the North American Pediatric Renal Transplant Cooperative Study. Kidney Int Suppl 1996;53:S68-S71.
20. Golper TA, Brier ME, Bunke M, Schreiber MJ, Bartlett DK, Hamilton RW, Strife F, Hamburger RJ: Risk factors for peritonitis in long-term peritoneal dialysis: The Network 9 peritonitis and catheter survival studies. Academic Subcommittee of the Steering Committee of the Network 9 Peritonitis and Catheter Survival Studies. Am J Kidney Dis 1996;28:428-436.
21. Weijmer MC, Vervloet MG, ter Wee PM: Prospective follow-up of a novel design hemodialysis catheter for the jugular site: Lower infection rates and improved survival. J Am Soc Nephrol 2001; 12:A1575.
22. Mickley V: Central venous catheters: Many questions, few answers. Nephrol Dial Transplant 2002;17:1368-1373.
23. Saad TF: Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis 1999;34:1114-1124.
24. Beathard GA: Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol 1999;10:1045-1049.
25. Lund GB, Trerotola SO, Scheel PFJ, Savader SJ, Mitchell SE, Venbrux AC, Osterman FA Jr: Outcome of tunneled hemodialysis catheters placed by radiologists. Radiology 1996;198:467-472.
26. Schwab SJ, Buller GL, McCann RL, Bollinger RR, Stickel DL: Prospective evaluation of a Dacron cuffed hemodialysis catheter for prolonged use. Am J Kidney Dis 1988;11:166-169.
27. Randolph AG, Cook DJ, Gonzales CA, Brun-Buisson C: Tunneling short-term central venous catheters to prevent catheter-related infection: A meta-analysis of randomized, controlled trials. Crit Care Med 1998;26:1452-1457.
28. Weijmer MC, van den Dorpel MA, ter Wee PM: Substantial reduction of infectious complications in hemodialysis patients with trisodium citrate 30% as catheter locking solution; a prospective multicenter double-blind randomised controlled trial. CITRATE Study Group. Nephrol Dial Transplant 2003;18:740.
29. Trerotola SO, Kraus MA, Shah H, Namyslowski J, Moresco K: Prospective randomized comparison of step-tip versus split-tip high flow tunneled hemodialysis catheters: Work in progress. J Am Soc Nephrol 1999;10:A1116.
30. Richard HM 3rd, Hastings GS, Boyd-Kranis RL, Murthy R, Radack DM, Santilli JG, Ostergaard C, Coldwell DM: A randomized, prospective evaluation of the Tesio, Ash split, and Opti-flow hemodialysis catheters. J Vasc Interv Radiol 2001;12:431-435.
31. Twardowski ZJ, Moore HL: Side holes at the tip of chronic hemodialysis catheters are harmful. J Vasc Access 2001;1:8-16.
32. De Wachter D, Deserranno D, Verdonck P: Hemodynamic characteristics of a temporary dual lumen catheter for hemodialysis. J Biomech, in press.
33. Weijmer MC, Vervloet MG, ter Wee PM: Long shotgun-tip femoral catheters have better immediate function, better actual blood flow and lower recirculation rates. Nephrol Dial Transplant 2003;18:737.
34. Twardowski ZJ, Seger RM: Dimensions of central venous structures in humans measured in vivo using magnetic resonance imaging: Implications for central-vein catheter dimensions. Int J Artif Organs 2002;25:107-123.
35. Weijmer MC, Kars SM, ter Wee PM: A scanning electron microscopy analysis of a spontaneous hemodialysis catheter fracture. Am J Kidney Dis 2001;38:858-861.
36. Trerotola SO, Kraus M, Shah H, Namyslowski J, Johnson MS, Stecker MS, Ahmad I, McLennan G, Patel NH, O'Brien E, Lane KA, Ambrosius WT: Randomized comparison of split tip versus step tip high-flow hemodialysis catheters. Kidney Int 2002;62:282-289.
37. Trerotola SO, Johnson MS, Shah H, Kraus MA, McKusky MA, Ambrosius WT, Harris VJ, Snidow JJ: Tunneled hemodialysis catheters: Use of a silver-coated catheter for prevention of infection - A randomized study. Radiology 1998;207:491-496.
38. Trerotola SO, Johnson MS, Harris VJ, Shah H, Ambrosius WT, McKusky MA, Kraus MA: Outcome of tunneled hemodialysis catheters placed via the right internal jugular vein by interventional radiologists. Radiology 1997;203:489-495.
39. Kwon TH, Kim YL, Cho DK: Ultrasound-guided cannulation of the femoral vein for acute haemodialysis access. Nephrol Dial Transplant 1997;12:1009-1012.
40. Farrell J, Gellens M: Ultrasound-guided cannulation versus the landmark-guided technique for acute haemodialysis access. Nephrol Dial Transplant 1997;12:1234-1237.
41. Lin BS, Huang TP, Tang GJ, Tarng DC, Kong CW: Ultrasound-guided cannulation of the internal jugular vein for dialysis vascular access in uremic patients. Nephron 1998;78:423-428.
42. Schwab SJ, Beathard G: The hemodialysis catheter conundrum: Hate living with them, but can't live without them. Kidney Int 1999;56:1-17.
43. Work J: Chronic catheter placement. Semin Dial 2001;14:436-440.
44. Guth AA: Routine chest X-rays after insertion of implantable long-term venous catheters: Necessary or not? Am Surg 2001;67:26-29.
45. Farrell J, Walshe J, Gellens M, Martin KJ: Complications associated with insertion of jugular venous catheters for hemodialysis: The value of postprocedural radiograph. Am J Kidney Dis 1997;30:690-692.
46. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S: Chlorhexidine compared with povidoneiodine solution for vascular catheter-site care: A meta-analysis. Ann Intern Med 2002;136:792-801.
47. Conly JM, Grieves K, Peters B: A prospective, randomized study comparing transparent and dry gauze dressings for central venous catheters. J Infect Dis 1989;159:310-319.
48. Sesso R, Barbosa D, Leme IL, Sader H, Canziani ME, Manfredi S, Draibe SA, Pignatari AC: Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: Effect of mupirocin ointment. J Am Soc Nephrol 1998;9:1085-1092.
49. Johnson DW, MacGinley R, Kay TD, Hawley CM, Campbell SB, Isbel NM, Hollett P: A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. Nephrol Dial Transplant 2002;17:1802-1807.
50. Lok CE, Stanley KE, Hux JE, Richardson R, Tobe SW, Conly J: Hemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol 2003;14:169-179.
51. Perez-Fontan M, Rosales M, Rodriguez-Carmona A, Falcon TG, Valdes F: Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am J Kidney Dis 2002;39:337-341.
52. Annigeri R, Conly JM, Vas SI, Dedier H, Prakashan KP, Bargman JM, Jassal V, Oreopoulos DG: Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit Dial Int 2001;21:554-559.
53. Bayes B, Bonal J, Romero R: Sodium citrate for filling haemodialysis catheters. Nephrol Dial Transplant 1999;14:2532-2533.
54. Moritz ML, Vats A, Ellis D: Systemic anticoagulation and bleeding in children with hemodial ysis catheters. Pediatr Nephrol 2003;18:68-70.
55. Costerton JW, Stewart PS, Greenberg EP: Bacterial biofilms: A common cause of persistent infections. Science 1999;284:1318-1322.
56. Dogra GK, Herson H, Hutchison B, Irish AB, Heath CH, Golledge C, Luxton G, Moody H: Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: A randomized controlled study. J Am Soc Nephrol 2002;13:2133-2139.
57. Weijmer MC, Debets-Ossenkopp YJ, Van de Vondervoort FJ, ter Wee PM: Superior antimicrobial activity of trisodium citrate over heparin for catheter locking. Nephrol Dial Transplant 2002;17: 2189-2195.
58. Ash SR, Mankus RA, Sutton JM, Criswell ER, Crull CC, Velasquez KA, Smeltzer BD, Ing TS: Concentrated sodium citrate (23%) for catheter lock. Hemodial Int 2000;4:22-31.
59. Weijmer MC, van den Dorpel MA, ter Wee PM: Reduction of bleeding complications in hemodialysis patients with high concentration trisodium citrate for hemodialysis catheter locking; a prospective multicenter double-blind randomised controlled trial. CITRATE Study Group. Nephrol Dial Transplant 2003;18:737.
60. FDA Issues Warning on triCitrasol® Dialysis Catheter Anticoagulant. FDA Talk Paper T00-16, April 14, 2000.